Welcome to the 8th Dermatology Drug Development Summit
Industry’s Destination to Discover & Develop Best-In-Class Drugs for Immuno-Inflammatory Skin Disease
Johnson & Johnson’s $2.1bn acquisitions of bispecific biotechs highlight the fierce competition to propel novel, best-in-class therapies for immuno-inflammatory skin disease to market. The past 12 months, the industry also witnessed Galderma, Incyte, and Eli Lilly share incredible late-stage clinical read-outs, though as disease heterogeneity reveals high unmet medical need, addressing both the challenges and opportunities this presents for drug developers is an industry priority.
Dedicated to unveiling how the most promising pipelines are tackling key industry challenges, the 8th Dermatology Drug Development Summit is the definitive forum for immuno-inflammatory drug developers.
In 2024, your unmissable program features late-breaking clinical data, immersive workshops for Hidradenitis Suppurativa, JAK inhibitors, and Indication Expansion Opportunities, plus specialized tracks focussed on Discovery & Translational advancements and Clinical & Commercialization strategies. Joining means teams leave equipped to transform cutting edge R&D into life-changing therapies, revolutionizing QoL and expanding access to ground-breaking treatments.
Providing an industry networking experience like no other, this November utilize 3 days to discuss the most novel dermatology innovations alongside 130+ experts amongst the likes of Johnson & Johnson Innovative Medicine, AbbVie, Alys Pharmaceuticals and LEO Pharma. Whether you’re C-Level, or advancing Discovery, Translational or Clinical programs, this is your opportunity to join field front-runners, exciting biotech and clinicians, quickly transforming the drug development landscape.
Don’t miss your opportunity to position your dermatology portfolio to address unmet need, with superior and long-lasting efficacy for patients this November!
2024's World-Class Speakers Include:
Proud to Partner With:
Lead & Hosting Partner:
Previous Attending Companies include:
